Flavoxate ( DrugBank: Flavoxate )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
226間質性膀胱炎(ハンナ型)1

226. 間質性膀胱炎(ハンナ型)


臨床試験数 : 145 薬物数 : 156 - (DrugBank : 51) / 標的遺伝子数 : 64 - 標的パスウェイ数 : 146
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1JPRN-jRCTs051210106
13/10/202113/10/2021ESTOC studyThe Effect of Suplatast Tosilate for interstitial Cystitis: A randomized controlled open-label trial - ESTOC study Interstitial cystitis
bladder, inflammation, pain;D018856
Participants will be randomly assigned to splatast group or control group.
In splatast group, splatast tosilate capsule 100 mg (1 capsule at a time) will be orally administered 3 times a day between meals for 3 months. In control group, flavoxate hydrochloride tablets 200 mg (1 tablet at a time) will be orally administered 3 times a day between meals for 3 months.
Torimoto KazumasaFujimoto KiyohideRecruiting>= 20age oldNot applicableBoth100Phase 2Japan